Clinical Trial

Multitarget Pulse Field Ablation Guided by Endocardial and Non-invasive Atrial Driver Mapping (PFA+ADM) Pilot Study. Development of an Ablation Strategy to Improve the Efficacy of Long Standing Atrial Fibrillation Ablation in Patients With High Comorbidity Burden or Heart Failure

Study acronym: PFA+ADM
Recruiting
View on ClinicalTrials.gov →
Summary
To assess the efficacy and safety of a percutaneous ablation strategy that targets multiple extrapulmonary structures as the Cox-Maze IV.
Trial Details
NCT Number NCT07118488
Lead Sponsor Fundacion para la Innovacion en Biomedicina (FIBMED)
Conditions Persistent Atrial Fibrillation Longstanding
Enrollment 50 participants
Start Date 2025-08
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-12